Results
|
|
1.
|
CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition. MedStar authors:
Year: 2019
Citation: - Journal of Oncology Print. 2019:6486173, 2019.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - AbdusSamad M, Aljehane L, Clark H, Dougherty R, Gaur A, Karna K, Kuo LW, McCarron E, Qin Q, Rosenthal DS, Simbulan-Rosenthal CM, Vakili S, Zhou H
|
|
|
2.
|
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. MedStar authors:
Year: 2019
Citation: - Lancet Oncology. 20(1):88-99, 2019 01.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE Jr, Graham ML, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Paik S, Rastogi P, Seay TE, Soori GS, Swain SM, Wade JL 3rd, Walshe JM, Wickerham DL, Wolmark N
|
|
|
3.
|
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. MedStar authors:
Year: 2024
Citation: - Journal of Clinical Oncology. 42(11):1288-1300, 2024 Apr 10.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
All authors: - Ganz PA, Bandos H, Spanic T, Friedman S, Muller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Duenas EM, Armstrong A, Im SA, Song CG, Zheng H, Sarosiek T, Sharma P, Geng C, Fu P, Rhiem K, Frauchiger-Heuer H, Wimberger P, t'Kint de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugere C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, Scheepers ED, Cameron D, Garber J, Geyer CE, Tutt ANJ
|
|
|
4.
|
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence. MedStar authors:
- Gupta, Vinay
- McCarron, Edward C
Year: 2021
Citation: - Journal for Immunotherapy of Cancer. 9(10), 2021 Oct.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Andtbacka R, Badarinath S, Bar A, Beck JT, Behl D, Beitsch P, Berger A, Blumenstein B, Bowles T, Butler MO, Claveau J, Curti B, Gastman B, Glaspy J, Gupta V, Hamid O, Hernandez-Aya L, Holtan SG, Hsueh E, Hyngstrom J, Jang S, Kalmadi S, Keech J, Kumar P, Levine E, Lewis KD, Lutzky J, Markovic SN, McCarron EC, Mihalcioiu C, Milhem M, Milton D, Padmanabhan A, Paramo J, Pecora A, Peterkin JJ, Philips P, Rapisuwon S, Sato T, Schmidt W, Shaheen MF, Slingluff CL, Thomas S, Travers JB, Weber R
|
|
|
5.
|
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors:
- McCarron, Edward C
- Swain, Sandra M
Year: 2018
Citation: - Journal of the National Cancer Institute. 110(2), 2018 Feb 01
Institution:
- MedStar Franklin Square Medical Center
- Washington Cancer Institute
Medline publication type:
All authors: - Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd
|
|
|
6.
|
Ten-year Update: NRG Oncology/NSABP B-42 Randomized Trial: Extended Letrozole Therapy in Early-stage Breast Cancer. MedStar authors:
- McCarron, Edward C
- Swain, Sandra M
Year: 2023
Citation: - Journal of the National Cancer Institute. 2023 May 15
Institution:
- Associate Dean for Research Development
- MedStar Franklin Square Medical Center
- MedStar Health
Medline publication type:
All authors: - Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Rastogi P, Soori GS, Swain SM, Wade JL, Walshe JM, Wolmark N
|
|
|
7.
|
|
